DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period
| SUNZEN BIOTECH BERHAD |
| Subject | Dealings Outside Closed Period |
| No | Salutation | Name | Designation | Description Of "Others" Designation |
MR |
LIM WEE CHUN |
Others |
Principal Officer |
|
| Type of Transaction | Acquired | |||
| Description of "Others" Type of Transaction | ||||
| Date of Transaction | 20 Dec 2023 | |||
| Description of Securities |
Ordinary Shares |
|||
| No of Securities Transacted | 12,813,559 | |||
| % of Securities Transacted | 1.647 | |||
| Consideration | Malaysian Ringgit (MYR) 0.295 | |||
| Remarks : |
Mr. Lim Wee Chun had on 20 December 2023 entered into a conditional shares sale agreement with Sunzen Biotech Berhad ("Sunzen") to acquire 12,813,559 Ordinary Shares of Sunzen subject to the fulfilment of the conditions precedent as set out in the conditional shares sale agreement. Please refer to the Company's announcement dated 20 December 2023 for more information.
Percentage of securities transacted is calculated based on the enlarged share capital of 778,082,697 ordinary shares following completion of the conditional share sale agreements dated 20 December 2023 on the assumption none of the 356,894,609 outstanding warrants 2022/2027 and 96,265,200 employees share options are exercised into new shares of the Company. |
Announcement Info
| Company Name | SUNZEN BIOTECH BERHAD |
| Stock Name | SUNZEN |
| Date Announced | 26 Dec 2023 |
| Category | Dealings in Listed Securities (Chapter 14 of Listing Requirements) |
| Reference Number | DLR-22122023-00011 |